PUBLIC CONTRACT · 2023

Aquisição de Medicamentos antirretrovíricos para o tratamento da infeção por VIH, ao abrigo do CPA 2022/40, para o HFF, para o ano 2023

Contract value: €3,690.00
Signed on: 28 February 2023
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9834659

PUBLISHED DESCRIPTION

10C0193923

Parties involved

Contracting body: Hospital Prof. Doutor Fernando Fonseca E.P.E.
Awardee: Mylan, Lda.
Place of performance: Portugal, Lisboa, Amadora
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: Mylan, Lda. · Tax ID 502248793
Bidder: ABBVIE, LDA. · Tax ID 510229050
Bidder: GENERIS - FARMACEUTICA SA · Tax ID 508107997

Values and timeline

Contract price: €3,690.00
Procedure base price: €32,763.00
Total effective price: Not reported on Portal BASE
Publication date: 2 March 2023
Award date: 28 February 2023
Signing date: 28 February 2023
Performance period: 60 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Monofator
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 259.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement: CP 2022/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 6353303

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts